WO2023041979 - METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY
National phase entry:
Publication Number
WO/2023/041979
Publication Date
23.03.2023
International Application No.
PCT/IB2022/000515
International Filing Date
14.09.2022
Title **
[English]
METHODS AND COMPOSITIONS FOR TREATING CANCER AND ENHANCING IMMUNE CHECKPOINT INHIBITOR EFFICACY
[French]
MÉTHODES ET COMPOSITIONS POUR LE TRAITEMENT DU CANCER ET L'AMÉLIORATION DE L'EFFICACITÉ D'UN INHIBITEUR DE POINT DE CONTRÔLE IMMUNITAIRE
Applicants **
GNUBIOTICS SCIENCES SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
ADESOKAN, Adeyemi
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
WYSS, Romain
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
MIAO, Yong
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
Inventors
ADESOKAN, Adeyemi
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
WYSS, Romain
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
MIAO, Yong
c/o Gnubiotice Sciences SA
Startlab, Biopole, BAT SE-B,
Route De La Corniche 5
1066 Epalinges, CH
Priority Data
63/244,227
14.09.2021
US
63/273,105
28.10.2021
US
63/296,431
04.01.2022
US
63/308,011
08.02.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 3785 | |
| EPO | Filing, Examination | 27005 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 673 | |
| USA | Filing, Examination | 16660 |
Total: 48717 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided herein are methods and compositions for treating a tumor or increasing the anti-cancer effectiveness of an immune checkpoint inhibitor using glycopeptide containing compositions.[French]
L'invention concerne des méthodes et des compositions permettant de traiter une tumeur ou d'augmenter l'efficacité anticancéreuse d'un inhibiteur de point de contrôle immunitaire à l'aide de compositions contenant des glycopeptides.